We are live on
!
Find out more
SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
31 hedge funds and large institutions have $23.5M invested in scPharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
5% more capital invested
Capital invested by funds: $22.5M → $23.5M (+$1.06M)
0.61% less ownership
Funds ownership: 40.28% → 39.67% (-0.61%)
11% less funds holding
Funds holding: 35 → 31 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
54% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 13
Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.28M |
| 2 |
EP
Eversept Partners
New York
|
+$570K |
| 3 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$196K |
| 4 |
Renaissance Technologies
New York
|
+$149K |
| 5 |
Millennium Management
New York
|
+$110K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.07M |
| 2 |
AIC
AWM Investment Company
New York
|
-$738K |
| 3 |
State Street
Boston,
Massachusetts
|
-$292K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$235K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$73.1K |
